Fortis Healthcare Sees Sharp Open Interest Surge Amid Bearish Momentum

Open Interest and Volume Dynamics

On 27 Mar 2026, Fortis Healthcare’s open interest (OI) in derivatives climbed to 28,646 contracts from 24,929 the previous session, marking an increase of 3,717 contracts or 14.91%. This rise in OI is accompanied by a futures volume of 6,578 contracts, reflecting active trading interest. The futures value stood at approximately ₹32,660 lakhs, while the options segment contributed a substantial ₹9,70,994 lakhs, culminating in a total derivatives value of ₹32,808 lakhs. The underlying stock price closed at ₹815, down 1.59% on the day.

The increase in open interest amid a declining price trend often indicates fresh positions being initiated rather than existing ones being squared off. This suggests that traders are either building new short positions anticipating further downside or accumulating long positions as a hedge or speculative bet on a potential rebound. The volume data supports this interpretation, as the futures volume remains robust despite the stock’s negative price action.

Technical and Trend Analysis

Fortis Healthcare’s technical indicators paint a cautious picture. The stock is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a sustained downtrend. After two consecutive days of gains, the stock reversed sharply, underperforming its hospital sector peers by 0.46% and the broader Sensex by 0.01%. The one-day return of -1.78% contrasts with the sector’s -1.17% and Sensex’s -1.58%, highlighting relative weakness.

Investor participation has also waned, with delivery volumes falling 12.14% against the five-day average, registering 11.64 lakh shares on 25 Mar. This decline in delivery volume suggests reduced conviction among long-term holders, potentially increasing volatility as short-term traders dominate price action.

Market Positioning and Potential Directional Bets

The surge in open interest amid falling prices and declining delivery volumes points to a market positioning shift. Traders may be increasing bearish bets, expecting further downside in Fortis Healthcare’s shares. Alternatively, some participants could be employing options strategies to hedge existing exposures or speculate on volatility spikes.

Given the stock’s mid-cap status with a market capitalisation of ₹62,258 crores and a recent downgrade in its Mojo Grade from Hold to Sell on 6 Mar 2026, market sentiment appears cautious. The Mojo Score of 30.0 reinforces this negative outlook, indicating weak fundamentals and technical momentum. This downgrade likely influences trader behaviour, encouraging short positions or protective hedges.

Comparative Sector and Market Context

Within the hospital sector, Fortis Healthcare’s recent performance lags behind peers, reflecting sector-wide pressures but also company-specific challenges. The sector’s 1-day return of -1.17% is less severe than Fortis’s -1.78%, underscoring relative underperformance. The broader market, represented by the Sensex, declined 1.58%, indicating that Fortis’s weakness is slightly more pronounced than the benchmark.

Liquidity remains adequate for sizeable trades, with the stock’s average traded value supporting a trade size of approximately ₹3.41 crores based on 2% of the five-day average. This liquidity facilitates active derivatives trading and supports the observed open interest expansion.

Implications for Investors and Traders

The combination of rising open interest, falling prices, and deteriorating technical indicators suggests that investors should exercise caution. The increased derivatives activity may signal that market participants are positioning for further downside or volatility. Investors with a long-term horizon may want to monitor for signs of stabilisation or a reversal in fundamentals before committing fresh capital.

Traders, on the other hand, might find opportunities in the heightened volatility and volume, employing strategies such as short selling, options spreads, or volatility plays. However, the stock’s mid-cap status and recent downgrade to a Sell rating by MarketsMOJO indicate underlying risks that could persist in the near term.

Outlook and Conclusion

Fortis Healthcare’s derivatives market activity reveals a notable increase in open interest amid a bearish price environment and weakening technical signals. The stock’s downgrade to a Sell rating and low Mojo Score reflect fundamental and momentum challenges that have tempered investor confidence. While the surge in open interest indicates active positioning, the directional bias appears skewed towards caution or bearishness.

Investors should closely monitor upcoming earnings, sector developments, and broader market trends to gauge whether Fortis Healthcare can stabilise or reverse its downtrend. Meanwhile, traders may capitalise on the increased volatility and liquidity, but must remain vigilant given the stock’s current risk profile.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today